A Look At BioMarin Pharmaceutical (BMRN) Valuation After Positive Voxzogo Phase 3 Trial Results Simply Wall St 09:23 Wed, 27 May
Roche and Nestlé fear talent crunch as Switzerland puts population cap to the polls Fortune 3d Switzerland Roche Swiss Economy
3 Reasons to buy Eli Lilly stock like there's no tomorrow The Motley Fool 1d Eli Lilly Novo Nordisk Mounjaro
Why Redwire stock plummeted this week The Motley Fool 1d Stock Markets (World) World Economic News Stock Market
Nikkei index rises on hopes of Middle East conflict end Yemen News Agency (Saba) 3d Nikkei Nikkei 225 World Conflicts
SpaceX is trading today – But what exactly are investors actually buying? Investomania 3d SpaceX Stock Markets (World) Flotations/IPOs
US Stock Market: Heavy demand anticipated as SpaceX options begin trading this week The Economic Times 4h Elon Musk Markets SpaceX All sources
Bitcoin nears $66K as Iran deal liquidates $246M shorts; token unlocks hit $670M Coinotag 3h Stock Markets (World) Markets Strait of Hormuz All sources
Hong Kong stocks rally after US says it reaches deal with Iran over oil flow South China Morning Post 8h Hong Kong Stock Markets (World) Markets All sources
Seoul stocks surge as US-Iran breakthrough boosts risk appetite The Korea Times 2h Seoul Iran Middle East
Bell Potter says this popular ASX 200 stock could deliver a 40% return The Motley Fool (Australia) 12h ASX Stock Market Markets
How safe is Bristol Myers Squibb's dividend? Here's my honest take. The Motley Fool 1d Bristol Myers Squibb Stock Market Markets
6 ASX shares with 35% to 75% growth ahead of them: experts The Motley Fool (Australia) 13h ASX Stock Market Markets
For the first time in over 155 years, the stock market may be headed here -- and it's not good news for investors The Motley Fool 15h S&P 500 Stock Market Stock Market (US)